Preventive hyperviscosity treatment is indicated whenever the patients met clinical symptoms and / or the plasma viscosity increases to 4 - 5cp, or level of plasma IgM ≥3 g / dl, or IgG ≥4 g / dl, or IgA ≥6 g/dl.